Table 1.
Baseline clinical characteristics
| Characteristic | No Composite (n = 97) | Composite (n = 40) | P |
|---|---|---|---|
| Age (years; mean ± SD) | 38 ± 13 | 41 ± 15 | 0.30 |
| Female (%) | 35 | 40 | 0.58 |
| Creatinine (μmol/L; median [IQR]) | 92 (45 to 354) | 129 (35 to 900) | 0.01 |
| SBP (mmHg; mean ± SD) | 129 ± 20 | 133 ± 23 | 0.39 |
| DBP (mmHg; mean ± SD) | 80 ± 13 | 81 ± 12 | 0.59 |
| Proteinuria (g/d; median [IQR]) | 1.4 (0.0 to 21.0) | 2.0 (0.0 to 9.9) | 0.10 |
| Initial treatment (%) | |||
| glucocorticoids | 9 | 23 | 0.04 |
| immunosuppressives | 2 | 13 | 0.01 |
| angiotensin blockade | 43 | 53 | 0.33 |
| omega 3 fatty acids | 22 | 13 | 0.21 |
DBP, diastolic BP; IQR, interquartile range.